Donor-Derived Cell-Free DNA: Attractive Biomarker Seeks a Context of Use

Angelica Pagliazzi; Oriol Bestard; Maarten Naesens

doi:10.3389/ti.2023.12406

Donor-Derived Cell-Free DNA: Attractive Biomarker Seeks a Context of Use

Transpl Int. 2023 Dec 1:36:12406. doi: 10.3389/ti.2023.12406. eCollection 2023.

Authors

Angelica Pagliazzi¹, Oriol Bestard², Maarten Naesens^{1

3}

Affiliations

¹ Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
² Kidney Transplant Unit, Nephrology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
³ Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.

No abstract available

Keywords: clinical utility; context of use; donor-derived cell-free DNA; post-transplant monitoring; predictive values.

Publication types

Comment

MeSH terms

Biomarkers
Cell-Free Nucleic Acids*
Humans
Kidney Transplantation*
Tissue Donors

Substances

Cell-Free Nucleic Acids
Biomarkers

Grants and funding

MN is the senior clinical investigator of the Research Foundation Flanders (F.W.O.) (1844019N). AP is supported by a PhD Fellowship grant from the Research Foundation Flanders (F.W.O.) (1S93023N).